Leukocyte integrins are fundamentally important in modulating adhesion to extracellular matrix components and to other cells. This integrin-mediated adhesion controls leukocyte arrest and extravasation during the onset of inflammatory responses. Moreover, integrin-ligand interactions trigger signaling pathways which may influence leukocyte phenotype and function at sites of inflammation. In the current studies, we evaluated the combinatorial effects of monocyte adhesion and IFNg on intracellular signaling pathways. IFNg triggers a well defined signal transduction pathway, which although not directly stimulated by monocyte adherence to fibronectin-(FN) or arginine-glycine-aspartate (RGD)-coated substrata, was significantly enhanced in these matrix-adherent cells. Compared to monocytes in suspension or adherent on plastic surfaces, monocytes adherent to FN or RGD exhibited a greater than 3 fold increase in steady state levels of IFNg-induced messenger RNA for the high affinity FcgRI receptor. By electrophoretic mobility shift assays, this increase in mRNA was associated with a 5-10 fold increase in the Stat1-containing DNA binding complex that binds to FcgRI promoter elements. Furthermore, the tyrosine phosphorylation of Stat1 and the tyrosine kinases JAK1 and JAK2 was significantly enhanced in RGD-adherent monocytes compared to control cells. These results suggest a novel mechanism by which integrin-mediated cell adhesion can modulate the magnitude of cytokine induced signal transduction pathways, thereby amplifying cellular events leading to monocyte activation and inflammation.

National Institute of Health (NIH)
Food and Drug Administration (FDA)
Intramural Research (Z01)
Project #
Application #
Study Section
Life Course and Prevention Research Review Committee (LCR)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost